Slootstra JW - Search Results

1

The Mr 193,000 vault protein is up-regulated in multidrug-resistant cancer cell lines.

Schroeijers AB, Siva AC, Scheffer GL, de Jong MC, Bolick SC, Dukers DF, Slootstra JW, Meloen RH, Wiemer E, Kickhoefer VA, Rome LH, Scheper RJ. Schroeijers AB, et al. Among authors: slootstra jw. Cancer Res. 2000 Feb 15;60(4):1104-10. Cancer Res. 2000. PMID: 10706131

2

Multidrug-resistant tumor cells remain sensitive to a recombinant interleukin-4-Pseudomonas exotoxin, except when overexpressing the multidrug resistance protein MRP1.

de Jong MC, Scheffer GL, Broxterman HJ, Hooijberg JH, Slootstra JW, Meloen RH, Kreitman RJ, Husain SR, Joshi BH, Puri RK, Scheper RJ. de Jong MC, et al. Among authors: slootstra jw. Clin Cancer Res. 2003 Oct 15;9(13):5009-17. Clin Cancer Res. 2003. PMID: 14581376

3

Peptide transport by the multidrug resistance protein MRP1.

de Jong MC, Slootstra JW, Scheffer GL, Schroeijers AB, Puijk WC, Dinkelberg R, Kool M, Broxterman HJ, Meloen RH, Scheper RJ. de Jong MC, et al. Among authors: slootstra jw. Cancer Res. 2001 Mar 15;61(6):2552-7. Cancer Res. 2001. PMID: 11289130

4

Proteasome inhibition and mechanism of resistance to a synthetic, library-based hexapeptide.

Oerlemans R, Berkers CR, Assaraf YG, Scheffer GL, Peters GJ, Verbrugge SE, Cloos J, Slootstra J, Meloen RH, Shoemaker RH, Dijkmans BAC, Scheper RJ, Ovaa H, Jansen G. Oerlemans R, et al. Invest New Drugs. 2018 Oct;36(5):797-809. doi: 10.1007/s10637-018-0569-x. Epub 2018 Feb 14. Invest New Drugs. 2018. PMID: 29442210 Free PMC article.

5

Mimotopes: realization of an unlikely concept.

Meloen RH, Puijk WC, Slootstra JW. Meloen RH, et al. Among authors: slootstra jw. J Mol Recognit. 2000 Nov-Dec;13(6):352-9. doi: 10.1002/1099-1352(200011/12)13:6<352::AID-JMR509>3.0.CO;2-C. J Mol Recognit. 2000. PMID: 11114068

6

Identification of new tag sequences with differential and selective recognition properties for the anti-FLAG monoclonal antibodies M1, M2 and M5.

Slootstra JW, Kuperus D, Plückthun A, Meloen RH. Slootstra JW, et al. Mol Divers. 1997;2(3):156-64. doi: 10.1007/BF01682203. Mol Divers. 1997. PMID: 9238646

7

Possible active site of the sweet-tasting protein thaumatin.

Slootstra JW, De Geus P, Haas H, Verrips CT, Meloen RH. Slootstra JW, et al. Chem Senses. 1995 Oct;20(5):535-43. doi: 10.1093/chemse/20.5.535. Chem Senses. 1995. PMID: 8564428

8

Structural aspects of antibody-antigen interaction revealed through small random peptide libraries.

Slootstra JW, Puijk WC, Ligtvoet GJ, Langeveld JP, Meloen RH. Slootstra JW, et al. Mol Divers. 1996 Feb;1(2):87-96. doi: 10.1007/BF01721323. Mol Divers. 1996. PMID: 9237197 Free PMC article.

9

Synthetic peptide vaccines: unexpected fulfillment of discarded hope?

Meloen RH, Langeveld JP, Schaaper WM, Slootstra JW. Meloen RH, et al. Among authors: slootstra jw. Biologicals. 2001 Sep-Dec;29(3-4):233-6. doi: 10.1006/biol.2001.0298. Biologicals. 2001. PMID: 11851321

10

Screening of a small set of random peptides: a new strategy to identify synthetic peptides that mimic epitopes.

Slootstra JW, Puijk WC, Ligtvoet GJ, Kuperus D, Schaaper WM, Meloen RH. Slootstra JW, et al. J Mol Recognit. 1997 Sep-Oct;10(5):217-24. J Mol Recognit. 1997. PMID: 9587871

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

35 results

Search Page